Literature DB >> 17379379

Evaluation of the performance of a modified Acute Physiology and Chronic Health Evaluation (APACHE II) scoring system for critically ill patients in emergency departments in Hong Kong.

Shin Yan Man1, Ka Man Chan, Fung Yi Wong, Kit Yi Wong, Chi Lap Yim, Paulina S K Mak, Chak Wah Kam, Chor Chiu Lau, Fei Lung Lau, Colin A Graham, Timothy H Rainer.   

Abstract

INTRODUCTION: Numerous prognostic predictive models have been developed for critically ill patients, many of which are primarily designed for use in intensive care units. The objective of this study was to evaluate the accuracy of a modified Acute Physiology and Chronic Health Evaluation (APACHE II) scoring system in predicting the mortality for critically ill patients managed in emergency department (ED) resuscitation rooms in Hong Kong.
METHOD: A multi-centre, prospective study was conducted for patients managed in the resuscitation rooms of the EDs of four major hospitals, including one university teaching hospital. The primary outcome measure was 14 day all-cause mortality and the secondary outcome measure was the length of stay in hospital.
RESULTS: Of 867 patients recruited between 4 and 30 April 2004, 106 (12.2%) patients died. The modified APACHE II score was found to be significantly higher in non-survivors compared to survivors (mean+/-S.D.: 21.2+/-7.7 versus 14.4+/-7.1, p<0.001). The area under the curve for modified APACHE II in predicting mortality was 0.743 (95% CI, 0.696-0.790).
CONCLUSION: The modified APACHE II score is only a moderate predictor of mortality for critically ill patients managed in the resuscitation rooms of EDs in Hong Kong. A more ED specific scoring method is required.

Entities:  

Mesh:

Year:  2007        PMID: 17379379     DOI: 10.1016/j.resuscitation.2006.12.015

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  3 in total

1.  Key components of the delirium syndrome and mortality: greater impact of acute change and disorganised thinking in a prospective cohort study.

Authors:  R A Diwell; D H Davis; V Vickerstaff; E L Sampson
Journal:  BMC Geriatr       Date:  2018-01-25       Impact factor: 3.921

2.  Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis.

Authors:  Guolian Xia; Ronglin Jiang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

3.  High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit.

Authors:  Xiang-Rong Bai; De-Chun Jiang; Su-Ying Yan
Journal:  Infect Drug Resist       Date:  2020-05-18       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.